Results 131 to 140 of about 6,976 (185)

129MO Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2-positive (HER2+) advanced gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric06 (DG-06) final analysis [PDF]

Lin Shen, Pengwan Chen, Jiuzhou Lu, Ying Wan, Y. Zheng, Fei Ye, Shuicheng Yan, Yixin Liu, Hui Pan, Hong Chen, Meili Sun, Qiao Fan, Yun Yuan, Kefei Chen, Zhi Sun, Hui Tian, Xiaofei Ye, Zhenyu Peng   +17 more
openalex   +1 more source

Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study. [PDF]

Breast Cancer Res
Azhar M, Soto F, Su A, Gonzalez NAV, Medina KB, Madrigal AL, Duran CC, Reyna CIR, Chan C, Shroff GS, Bassett RL, Pasyar S, Zhang D, Shannon VR, Altan M, Mitchell MP, Meric-Bernstam F, Mouabbi J, Murthy RK, Faiz SA, Bashoura L, Lim B, Sheshadri A.   +22 more
europepmc   +1 more source

Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of randomized controlled trials

Hsiao, Sheng-Yen, Lin, Wei-Ting, Lin, Cheng-Yao, Chao, Chien-Ming, Weng, Teng-Song   +4 more
openalex   +1 more source

Trastuzumab deruxtecan in an elderly patient with HR+/HER2-low breast cancer complicated by pleural effusion: a case report and literature review. [PDF]

Front Oncol
Huang S, Law S, Chen M, Lai H.
europepmc   +1 more source

Real-world outcomes of trastuzumab deruxtecan in HR-negative HER2-low metastatic breast cancer. [PDF]

NPJ Breast Cancer
Ni M, Wang D, Dun S, Zhou Q, Xia W, Hong R, Shi Y, Yuan Z, Huang J, Xu F, Li L, Cao Y, Pang D, Wang S, An X.   +14 more
europepmc   +1 more source

Effusion Reduction after Early Trastuzumab Deruxtecan Therapy for Unresectable HER2-Low Breast Cancer in an Older Patient: A Case Report. [PDF]

Surg Case Rep
Akabane A, Kawai M, Suzuki K, Goto A, Tanaka T, Futakuchi M, Motoi F.   +6 more
europepmc   +1 more source

Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases? [PDF]

Rupert Bartsch, Matthias Preusser
openalex   +1 more source

Trastuzumab Deruxtecan for brain metastatic squamous lung carcinoma with immune-related hypophysitis: a case report. [PDF]

Front Pharmacol
Xu R, Gan J, Zhang J, Yang L, Liu Y, Li W, Wang K, Liu D.   +7 more
europepmc   +1 more source

Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center. [PDF]

Curr Oncol
Alanazi AS, Alanazi AA, Alanizi A, Babalghaith R, Alotaibi R, Alnuhait M, Bakhribah H.   +6 more
europepmc   +1 more source

Efficacy and safety of trastuzumab deruxtecan for metastatic HER2+ and HER2-low breast cancer: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Mu Y, Li J, Fan Y, Pei X.
europepmc   +1 more source